Connect with 
Lilly Tempo™

Dexcom G7 and the TempoSmart Platform connect to help support your diabetes management. Simplify your daily tasks with features like logging insulin doses, dosing reminders, insulin dose calculator, and activity monitoring.
  • Explore Tempo

See the whole picture, not just a snapshot—in one place

With Dexcom and Tempo, you can see your CGM data together with your insulin dosing information​.

One place to view your info

See your data about your insulin, glucose, dosing, food, and sleep activity within the TempoSmart App.
Smart device sold separately.*

Reminders and tracking​

Set up personalized reminders and notifications† alongside your dose tracking.

Share your Logbook​

You can provide your healthcare provider with access to review at visits—helping you make the most of your time together.
Smart device sold separately.*

Guess less, dose smarter

Dexcom G7
The most accurate CGM system1,2 that communicates with the TempoSmart app
TempoSmart™ App
Integrates your insulin dosing data with your 
Dexcom CGM numbers, food, exercise, and sleep data
Tempo Pen​™
Disposable pre-filled insulin pen that works with the Tempo Smart Button
Tempo Smart Button™
Attaches to your Tempo Pen and transfers your insulin dose-related data automatically to the TempoSmart App when paired

Meet our CGM family

Dexcom G6 and Dexcom G7 offer powerful glucose monitoring that’s made for connections, letting you view your glucose data on any compatible smart device.*
  • Get started
  • Check device compatibility

Do you have questions about Lilly Tempo?

Learn more about who to contact for support and FAQs
*Compatible smart device sold separately. For a list of compatible devices, visit dexcom.com/compatibility. †Alerts and notifications must be enabled by the user during initial setup of the TempoSmart App. ‡To transfer your insulin dose-related data automatically, the Tempo Smart Button must be connected to the app and be within 9 feet (3 meters) of your Bluetooth® enabled mobile device. You can also enter your insulin dosing information manually.
1 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K213919. Published December 7, 2022. https://www.accessdata.fda.gov/cdrh_docs/reviews/K213919.pdf. 2 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K222447. Published March 3, 2023. https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. 
Tempo™, Tempo Smart Button™, Tempo Pen™, TempoSmart™, and Tempo Insights™ are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
 
Privacy PolicyTerms of Use

LBL-1001419 Rev008

MAT-1010

© Dexcom, Inc. All rights reserved.

US flag

US